Geoffrey P. Gilmore's Insider Trades & SAST Disclosures
Geoffrey P. Gilmore's most recent trade in Agile Therapeutics Inc was a trade of 13,500 Common Stock done . Disclosure was reported to the exchange on June 28, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Geoffrey P. Gilmore.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Agile Therapeutics Inc | Geoffrey P. Gilmore | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 13,500 | 13,540 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | Geoffrey P. Gilmore | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 6,716 | 20,256 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | Geoffrey P. Gilmore | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 4,500 | 4,500 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Geoffrey P. Gilmore | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 10,000 | 10,000 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Geoffrey P. Gilmore | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 225,000 | 225,000 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Geoffrey P. Gilmore | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 259,740 | 259,740 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges